Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.
about
Tachykinin receptors and tachykinin receptor antagonistsAnxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.Innervation of the synoviumThe role of substance P in stress and anxiety responses.New insights into the antidepressant actions of substance P (NK1 receptor) antagonists.Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists.Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.[3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.Animal models of depression: are there any?Role of substance P in inflammatory arthritis.Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptors.Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the ratEffect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits.Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.Characterisation of the response of equine digital arteries and veins to substance P.Internal and external factors affecting the development of neuropathic pain in rodents. Is it all about pain?Functional mapping of the ligand binding sites of G-protein coupled receptors.Tachykinin receptors: a radioligand binding perspective.Substance P-evoked calcium mobilization and ionic current activation in the human astrocytoma cell line U 373 MG: pharmacological characterization.Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580.Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykininsComparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats.A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea.Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.Pharmacological characterization of the contractile responses to angiotensin analogues in guinea-pig isolated longitudinal muscle of small intestine.The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat.Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.
P2860
Q28262983-E51615A8-B71B-4C52-839B-A3BAE667FD2BQ30479172-61072CB8-1ED7-4A81-92CA-5481A034FC5DQ33567300-1359AB15-F5F6-44E4-A2D2-5AA2070AFC37Q33997424-7DB7C598-5F96-47EC-A7E1-7A9DB0801AA3Q34132678-3772CCAB-F947-481B-AD9D-712326E88B70Q34697510-06945D0A-CEF4-42BD-B40B-01A9B165D36EQ34793730-8FDD4823-58E9-4533-BE2F-1E4BE145E481Q35100845-27800B59-B153-450B-BC80-AA2D6C06203FQ35136039-2C521084-C255-42B6-853A-07315446B0EDQ35342904-6DEFCBFC-F551-4054-98B9-222609EC05D2Q35870984-5E1ABE94-E873-42A0-8353-AA859FA113C3Q35871233-AE9E070B-4D28-4AB6-ADD0-9C57FF148166Q35873011-06EB6E15-336D-493C-93E8-6CB3ED004E12Q35873358-E926DD12-5D9A-465A-9E73-0176F36A5232Q36330416-AFFE6086-12AF-473F-B8AE-5069915EA8FDQ38336515-A56B5832-7C0C-4C63-92A6-EB2A4A919F33Q39669857-2AA42922-5223-4610-B1EF-C4410E6E9ABBQ40260717-0FCCD6D4-161F-4867-9EE7-4F740E0F07EFQ40701831-F783C17E-D772-4744-A19A-F294DA7E181DQ40853954-A97A223B-DF6F-46E6-A652-64C6B40383AAQ41519084-72E1B738-8D00-4711-8234-580445D58D04Q41764247-BA70EF27-B90C-4561-B7B5-320AFF1F5F39Q41790903-B476492A-81D7-4C9F-AED0-AE86D09AFE67Q41840406-409A60E5-EFA7-4EAC-B9E1-57EB0EBB7B48Q41872098-96AAD569-D8A9-4F3D-A15B-A88CDB265D78Q41885307-0791555C-778E-4399-A627-5D8D45F5DE5CQ41951832-654B0C6F-3DC8-4773-BE9F-29B3A881C043Q41957034-8C3FBC0A-3255-4232-9436-FFC097CF3CA9Q41976591-D9B1C798-8915-4F7C-AAC5-A8AC41318DE6Q42017469-F7A57BC2-5980-4D3E-A6B6-39FE8D5FB90BQ42063978-DB59BEE6-5C47-4B4E-8B24-895ABBC2EB54Q42091391-398283EB-AF37-4907-BEC8-F46CFD7FF1F6Q42129735-D4F0E766-D04A-4FB4-9FAE-8B5E258C1050Q42238959-2E135027-0B8E-4AF6-B1F1-B639CAB87D22Q42370128-3D382E46-B786-43C6-9AF0-8CD4E056B1ADQ42370983-33599F34-9114-4E84-84F5-D802ABB2DB20Q42701410-06CB5E13-DB7D-48E2-B040-E6CBFA78AD1EQ42706973-C5238458-CBB4-458D-B269-DC98FB20CABFQ42716479-C82BAF55-9EC8-46CF-95CF-5EA780266886Q42920439-6099491B-430C-4B24-B6FC-92788386D2A0
P2860
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Investigation into species var ...... peptide antagonist, CP-96,345.
@en
Investigation into species var ...... peptide antagonist, CP-96,345.
@nl
type
label
Investigation into species var ...... peptide antagonist, CP-96,345.
@en
Investigation into species var ...... peptide antagonist, CP-96,345.
@nl
prefLabel
Investigation into species var ...... peptide antagonist, CP-96,345.
@en
Investigation into species var ...... peptide antagonist, CP-96,345.
@nl
P2093
P2860
P1476
Investigation into species var ...... peptide antagonist, CP-96,345.
@en
P2093
I J Beresford
S J Ireland
P2860
P304
P356
10.1111/J.1476-5381.1991.TB12423.X
P407
P577
1991-10-01T00:00:00Z